Oregon Public Employees Retirement Fund Arvinas, Inc. Transaction History

Oregon Public Employees Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2020	SELL	$29.88 - $56.74 $658,794 - $1.25 Million	-22,048 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$33.0 - $54.5 $562,584 - $929,116	17,048 Added 340.96%	22,048 $889,000
Q4 2019 Feb 05, 2020	SELL	$15.39 - $44.38 $304,798 - $878,945	-19,805 Reduced 79.84%	5,000 $205,000
Q3 2019 Nov 07, 2019	BUY	$21.55 - $27.61 $534,547 - $684,866	24,805 New	24,805 $535,000

227

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $910M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.